TVARDI THERAPEUTICS, INC. Debt Securities, Available-for-sale, Current
TVARDI THERAPEUTICS, INC. (TVRD) had Debt Securities, Available-for-sale, Current of $110.79 million as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2022-08-08
- 2022-06-30: Debt Securities, Available-for-sale, Current $110.79M.
- 2022-03-31: Debt Securities, Available-for-sale, Current $119.75M.
- 2021-12-31: Debt Securities, Available-for-sale, Current $153.58M.
- 2021-09-30: Debt Securities, Available-for-sale, Current $121.20M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2022-06-30 | $110.79M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $119.75M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $153.58M 10-Q · filed 2022-08-08 |
| 2021-09-30 | $121.20M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $132.84M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $149.06M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $149.24M 10-K · filed 2022-03-01 |
| 2020-09-30 | $45.59M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $73.22M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $103.16M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $136.70M 10-K · filed 2021-02-25 |
| 2019-09-30 | $158.38M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $96.81M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $120.27M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $146.30M 10-K · filed 2020-02-27 |
| 2018-09-30 | $109.35M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $114.16M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $62.64M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $83.18M 10-K · filed 2019-03-12 |
| 2016-12-31 | $46.18M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |